or
forgot password
  • cancer clinical trials in branson, MO

  • Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Skaggs Cancer Center at Skaggs Regional Medical Center
    Branson, Missouri 65616
    Breast Cancer
    Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer
    Research Site
    Branson, Missouri
    Thyroid Cancer
    Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
    Branson Oncology Clinic
    Branson, Missouri 65616
    Chronic Lymphocytic Leukemia
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Skaggs Cancer Center
    Branson, Missouri 65616
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
    Research Site
    Branson, Missouri
    Breast Neoplasms
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Skaggs Cancer Center at Skaggs Regional Medical Center
    Branson, Missouri 65616
    Colorectal Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Skaggs Cancer Center at Skaggs Regional Medical Center
    Branson, Missouri 65616
    Prostate Cancer
    STEPP: A Phase 2, Open-label, Randomized Clinical Trial of Skin Toxicity Treatment in mCRC Subjects Receiving Panitumumab Concomitantly With Second-line Irinotecan Based Chemotherapy
    Research Site
    Branson, Missouri
    Metastatic Colorectal Cancer, Skin Rash, Skin Toxicities, Colon Cancer, Colorectal Cancer
    First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
    Research Site
    Branson, Missouri
    Colorectal Cancer
    PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
    Research Site
    Branson, Missouri
    Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Skaggs Cancer Center
    Branson, Missouri 65616
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Skaggs Cancer Center
    Branson, Missouri 65616
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Skaggs Cancer Center
    Branson, Missouri 65616
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer
    Research Site
    Branson, Missouri
    Metastatic Colorectal Cancer, Colon Cancer, Colorectal Cancer, Rectal Cancer
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Skaggs Cancer Center
    Branson, Missouri 65616
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Skaggs Cancer Center at Skaggs Regional Medical Center
    Branson, Missouri 65616
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Skaggs Cancer Center
    Branson, Missouri 65616
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
    Research Site
    Branson, Missouri
    Cancer, Oncology, Tumors, Advanced Malignancy, Advanced Solid Tumors, Oncology Patients
    Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
    Research Site
    Branson, Missouri
    Non-Small Cell Lung Cancer, Anemia, Cancer, Lung Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Skaggs Cancer Center
    Branson, Missouri 65616
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Skaggs Cancer Center at Skaggs Regional Medical Center
    Branson, Missouri 65616
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    PAVES: Pegfilgrastim Anti-VEGF Evaluation Study
    Research Site
    Branson, Missouri
    Cancer, Colon Cancer, Colorectal Cancer, Fever, Locally Advanced, Metastatic Colorectal Cancer, Neutropenia, Rectal Cancer
    A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
    Research Site
    Branson, Missouri
    Cancer, Cataract, Low Bone Mineral Density, Osteopenia, Osteoporosis, Prostate Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Skaggs Cancer Center
    Branson, Missouri 65616
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
    Skaggs Cancer Center at Skaggs Regional Medical Center
    Branson, Missouri 65616
    Leukemia
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Skaggs Cancer Center
    Branson, Missouri 65616
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
    Skaggs Cancer Center
    Branson, Missouri 65616
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Solar Radiation-related Skin Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    Skaggs Cancer Center at Skaggs Regional Medical Center
    Branson, Missouri 65616
    Breast Cancer
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Skaggs Cancer Center
    Branson, Missouri 65616
    Light Chain Deposition Disease, Smoldering Multiple Myeloma
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Skaggs Cancer Center
    Branson, Missouri 65616
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
    Research Site
    Branson, Missouri
    Cancer, Hematologic Malignancies, Multiple Myeloma, Oncology, Bone Metastases, Multiple Myeloma Bone Lesions
    Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
    Research Site
    Branson, Missouri
    Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP), Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP), Thrombocytopenic Purpura
    AMG 172 First in Human Study in Patients With Kidney Cancer
    Research Site
    Branson, Missouri
    Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma
    A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.
    Research Site
    Branson, Missouri
    Hormone Receptor Positive Breast Cancer
    Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
    Research Site
    Branson, Missouri
    N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma
    NOLAN: Naproxen or Loratadine and Neulasta
    Research Site
    Branson, Missouri
    Bone Pain in Stage I - III Breast Cancer
    Video Impact on Neulasta Education
    Research Site
    Branson, Missouri
    Breast Cancer
    Armodafinil in Reducing Cancer-Related Fatigue in Patients With Glioblastoma Multiforme
    Cox Cancer Center Skaggs Community Health Center - Branson
    Branson, Missouri 65616
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Fatigue
    Iressa Expanded Access Program (EAP)
    Research Site
    Branson, Missouri
    Carcinoma, Non-small-cell Lung, Metastases, Neoplasm
    Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma
    Research Site
    Branson, Missouri
    Non-Hodgkin's Lymphoma
    This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.
    Research Site
    Branson, Missouri
    Carcinoma, Non-Small-Cell Lung
    ABX-EGF Monotherapy in Subjects With Metastatic Colorectal Cancer
    Research Site
    Branson, Missouri
    Colorectal Cancer, Metastases
    The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
    Research Site
    Branson, Missouri
    Breast Neoplasms, Neoplasms, Hormone-Dependent
    GALLANT 5 Tesaglitazar Versus Metformin
    Research Site
    Branson, Missouri
    Diabetes Mellitus, Type 2
    PROACT - Pre-Operative Arimidex Compared To Tamoxifen
    Research Site
    Branson, Missouri
    Breast Cancer
    GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin
    Research Site
    Branson, Missouri
    Type 2 Diabetes Mellitus
    Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
    AOI Pharmaceuticals Investigative Site
    Branson, Missouri 65616
    Colon Cancer
    A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer
    Research Site
    Branson, Missouri
    Adenocarcinoma of the Pancreas, Metastatic Pancreatic Cancer, Pancreatic Cancer
    Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer
    Research Site
    Branson, Missouri
    Non-metastatic Prostate Cancer